Sign Up Today and Learn More About Chengdu Pukang Biotechnology Co. Stock

Invest in or calculate the value of your shares in Chengdu Pukang Biotechnology Co. or other pre-IPO companies through EquityZen's platform.

Get Started

Chengdu Pukang Biotechnology Co. Stock

Chengdu Pukang Biotechnology Co., Ltd develops and supplies PEG derivatives, polypeptide drug side chains, and intermediates.

About Chengdu Pukang Biotechnology Co. Stock

Founded

2008

Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development and manufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Locked Features

Join now and verify your accreditation status to gain access to:

  • Chengdu Pukang Biotechnology Co. current valuation
  • Chengdu Pukang Biotechnology Co. stock price
  • Available deals in Chengdu Pukang Biotechnology Co. and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Chengdu Pukang Biotechnology Co. stock?

Accredited investors can buy pre-IPO stock in companies like Chengdu Pukang Biotechnology Co. through EquityZen funds. These investments are made available by existing Chengdu Pukang Biotechnology Co. shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Chengdu Pukang Biotechnology Co. stock?

Shareholders can sell their Chengdu Pukang Biotechnology Co. stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."